Clinical Trial

Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia

Name: Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia — clinical trial record (NCT07458542)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess real-world effectiveness and safety of oral azacitidine in adults diagnosed with acute myeloid leukemia (AML) in Hong Kong

Trial Details

NCT Number	NCT07458542
Lead Sponsor	Bristol-Myers Squibb
Conditions	Acute Myeloid Leukemia (AML)
Enrollment	44 participants
Start Date	2025-12-09
Primary Completion	2026-01-09 (estimated)
Study Completion	2026-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-09